4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-095402
Director sold 183,834 shares at an average $42.85 ($7,877,091)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kersten Dirk Director | 2024-08-08 | Sale 10b5-1 | −6,377 | $40.74 | $259,799 | 6,410,416 | I: show line 1 in the form |
| Kersten Dirk Director | 2024-08-08 | Sale 10b5-1 | −16,357 | $42.97 | $702,860 | 6,394,059 | I: show line 2 in the form |
| Kersten Dirk Director | 2024-08-08 | Sale 10b5-1 | −68,936 | $42.87 | $2,955,286 | 6,325,123 | I: show line 3 in the form |
| Kersten Dirk Director | 2024-08-09 | Sale 10b5-1 | −50,736 | $42.55 | $2,158,817 | 6,274,387 | I: show line 4 in the form |
| Kersten Dirk Director | 2024-08-09 | Sale 10b5-1 | −40,268 | $43.44 | $1,749,242 | 6,234,119 | I: show line 5 in the form |
| Kersten Dirk Director | 2024-08-09 | Sale 10b5-1 | −1,160 | $44.04 | $51,086 | 6,232,959 | I: show line 6 in the form |
| Open-market sales · 183,834 sh · avg $42.85 · $7,877,091 | |||||||
Loading xslF345X05/ownership.xml…